Literature DB >> 10851060

Control of myeloid differentiation and survival by Stats.

T E Smithgall1, S D Briggs, S Schreiner, E C Lerner, H Cheng, M B Wilson.   

Abstract

Hematopoiesis involves a complex array of growth factors that regulate the survival and proliferation of immature progenitors, influence differentiation commitment, and modulate end-stage cell functions. This mini-review is focused on the role of Stat activation in the development of myeloid cells in response to hematopoietic cytokines. Much of the evidence implicating Stats in these cellular processes comes from studies of mutant cytokine receptors selectively uncoupled from Stat activation, dominant-inhibitory Stat mutants, and mice with targeted disruptions of Stat genes. Together these approaches provide strong evidence that Stat activation, particularly of Stat3 and Stat5, plays an important role in myeloid differentiation and survival. Oncogene (2000).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10851060     DOI: 10.1038/sj.onc.1203477

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  33 in total

1.  Systemic levels of G-CSF and interleukin-6 determine the angiogenic potential of bone marrow resident monocytes.

Authors:  Alyssa D Gregory; Benjamin J Capoccia; Jill R Woloszynek; Daniel C Link
Journal:  J Leukoc Biol       Date:  2010-03-30       Impact factor: 4.962

2.  An oral HemokineTM, α-methylhydrocinnamate, enhances myeloid and neutrophil recovery following irradiation in vivo.

Authors:  Douglas V Faller; Serguei A Castaneda; Daohong Zhou; Merriline Vedamony; Peter E Newburger; Gary L White; Stanley Kosanke; P Artur Plett; Christie M Orschell; Michael S Boosalis; Susan P Perrine
Journal:  Blood Cells Mol Dis       Date:  2016-10-31       Impact factor: 3.039

3.  The Tumor Suppressive Effects of HPP1 Are Mediated Through JAK-STAT-Interferon Signaling Pathways.

Authors:  Jonathan M Hernandez; Abul Elahi; Whalen Clark; Leigh Ann Humphries; Jian Wang; Alex Achille; Ed Seto; David Shibata
Journal:  DNA Cell Biol       Date:  2015-05-19       Impact factor: 3.311

4.  Signal transducer and activator of transcription 5b (Stat5b) serine 193 is a novel cytokine-induced phospho-regulatory site that is constitutively activated in primary hematopoietic malignancies.

Authors:  Abhisek Mitra; Jeremy A Ross; Georgialina Rodriguez; Zsuzsanna S Nagy; Harry L Wilson; Robert A Kirken
Journal:  J Biol Chem       Date:  2012-03-22       Impact factor: 5.157

Review 5.  Therapeutic potential of Janus-activated kinase-2 inhibitors for the management of myelofibrosis.

Authors:  Srdan Verstovsek
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

Review 6.  Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis.

Authors:  Joanne Turner; Jordi B Torrelles
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

Review 7.  STAT3 regulation of glioblastoma pathogenesis.

Authors:  Núria de la Iglesia; Sidharth V Puram; Azad Bonni
Journal:  Curr Mol Med       Date:  2009-06       Impact factor: 2.222

8.  Requirement of STAT3 activation for differentiation of mucosal stratified squamous epithelium.

Authors:  Rong Wu; Shishinn Sun; Bettie M Steinberg
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

9.  Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock.

Authors:  Jixin Zhong; Ping Yang; Kenjiro Muta; Robert Dong; Mario Marrero; Feili Gong; Cong-Yi Wang
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

10.  Effects of dasatinib on SRC kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells.

Authors:  Heiko Konig; Mhairi Copland; Su Chu; Richard Jove; Tessa L Holyoake; Ravi Bhatia
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.